C84.72
Anaplastic large cell lymphoma, ALK-negative, intrathoracic lymph nodes
Clinical Classification Guidelines
Medical Intelligence & Overview
Anaplastic large cell lymphoma (ALCL) is a type of non-Hodgkin lymphoma, a cancer that originates in the lymphatic system. The ALK-negative variant refers to cases where the abnormal cells lack a specific protein called anaplastic lymphoma kinase (ALK). When this type affects lymph nodes within the chest (intrathoracic lymph nodes), it presents distinct clinical features. Understanding this condition helps patients and caregivers navigate diagnosis, treatment options, and prognosis.
Causes & Symptoms
Clinical Causes: Genetic mutations leading to abnormal cell growth Chronic immune system activation Possible environmental or occupational exposures (though specific causes are not well established) In some cases, associated with other lymphoid or myeloid malignancies
Key Symptoms: Swelling or lumps in the chest or neck area Persistent cough or shortness of breath Chest pain or discomfort Unexplained weight loss Fever and night sweats Fatigue and weakness Recurrent infections due to immune system involvement
Diagnostic & Treatment
Diagnosis Path: Imaging studies such as CT scans or PET scans to assess the extent of disease Laboratory tests, including blood counts and biochemical profiles Immunohistochemistry to detect specific markers like the absence of ALK protein Molecular genetic tests to rule out other lymphoma subtypes
Treatment Protocols: Chemotherapy regimens tailored for lymphoma, often involving combinations of drugs Targeted therapies and immunotherapy in some cases Radiation therapy to specific affected areas Stem cell transplantation in advanced or refractory cases Supportive care to manage symptoms and maintain quality of life
Clinical Advice & FAQs
Billing Guidance
Is C84.72 a billable ICD-10 code?
Yes, C84.72 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C84.72?
Clinical documentation must specify the nature of Anaplastic large cell lymphoma, ALK-negative, intrathoracic lymph nodes and any associated comorbidities for accurate reporting.
Cite this Clinical Reference